8.1
CVE-2020-10627
- EPSS 0.09%
- Veröffentlicht 01.12.2021 16:15:07
- Zuletzt bearbeitet 21.11.2024 04:55:43
- Quelle ics-cert@hq.dhs.gov
- CVE-Watchlists
- Unerledigt
Insulet Omnipod Insulin Management System insulin pump product ID 19191 and 40160 is designed to communicate using a wireless RF with an Insulet manufactured Personal Diabetes Manager device. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with access to one of the affected insulin pump models may be able to modify and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.
Daten sind bereitgestellt durch National Vulnerability Database (NVD)
Insulet ≫ Omnipod Insulin Management System Firmware Version-
Insulet ≫ Omnipod Insulin Management System Version19191
Insulet ≫ Omnipod Insulin Management System Version40160
Insulet ≫ Omnipod Insulin Management System Version40160
| Typ | Quelle | Score | Percentile |
|---|---|---|---|
| EPSS | FIRST.org | 0.09% | 0.252 |
| Quelle | Base Score | Exploit Score | Impact Score | Vector String |
|---|---|---|---|---|
| nvd@nist.gov | 8.1 | 2.8 | 5.2 |
CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N
|
| nvd@nist.gov | 4.8 | 6.5 | 4.9 |
AV:A/AC:L/Au:N/C:P/I:P/A:N
|
| ics-cert@hq.dhs.gov | 7.3 | 2.5 | 4.7 |
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:L
|
CWE-284 Improper Access Control
The product does not restrict or incorrectly restricts access to a resource from an unauthorized actor.